{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:59:10Z","timestamp":1794344350540,"version":"4.9.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FWO Vlaanderen,","award":["G0C8517N"],"award-info":[{"award-number":["G0C8517N"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10875-018-0525-8","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:40:24Z","timestamp":1530060024000},"page":"569-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":370,"title":["Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-0302","authenticated-orcid":false,"given":"Isabelle","family":"Meyts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Aksentijevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,27]]},"reference":[{"issue":"10","key":"525_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911\u201320.","journal-title":"N Engl J Med"},{"issue":"10","key":"525_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10):921\u201331.","journal-title":"N Engl J Med"},{"issue":"1","key":"525_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1073\/pnas.75.1.446","volume":"75","author":"WP Schrader","year":"1978","unstructured":"Schrader WP, Pollara B, Meuwissen HJ. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency. Proc Natl Acad Sci U S A. 1978;75(1):446\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"525_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF01115116","volume":"2","author":"HA Simmonds","year":"1982","unstructured":"Simmonds HA, Webster DR, Perrett D, Reiter S, Levinsky RJ. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency. Biosci Rep. 1982;2(5):303\u201314.","journal-title":"Biosci Rep"},{"issue":"2","key":"525_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.1109764","volume":"88","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88(2):279\u201390.","journal-title":"J Leukoc Biol"},{"issue":"Pt 1","key":"525_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/BJ20050683","volume":"391","author":"AV Zavialov","year":"2005","unstructured":"Zavialov AV, Engstrom A. Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity. Biochem J. 2005;391(Pt 1):51\u20137.","journal-title":"Biochem J"},{"issue":"1","key":"525_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaci.2014.10.010","volume":"135","author":"L Eyck Van Jr","year":"2015","unstructured":"Van Eyck L Jr, Hershfield MS, Pombal D, Kelly SJ, Ganson NJ, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135(1):283\u20137 e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"525_CR8","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1182\/blood-2009-06-189209","volume":"114","author":"HB Gaspar","year":"2009","unstructured":"Gaspar HB, Aiuti A, Porta F, Candotti F, Hershfield MS, Notarangelo LD. How I treat ADA deficiency. Blood. 2009;114(17):3524\u201332.","journal-title":"Blood"},{"issue":"6","key":"525_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00431-014-2320-8","volume":"173","author":"N Garg","year":"2014","unstructured":"Garg N, Kasapcopur O, Foster J 2nd, Barut K, Tekin A, Kizilkilic O, et al. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr. 2014;173(6):827\u201330.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"525_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/eji.200425738","volume":"35","author":"MS Hershfield","year":"2005","unstructured":"Hershfield MS. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur J Immunol. 2005;35(1):25\u201330.","journal-title":"Eur J Immunol"},{"issue":"9","key":"525_CR11","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1002\/eji.200738094","volume":"38","author":"S Minguet","year":"2008","unstructured":"Minguet S, Dopfer EP, Pollmer C, Freudenberg MA, Galanos C, Reth M, et al. Enhanced B-cell activation mediated by TLR4 and BCR crosstalk. Eur J Immunol. 2008;38(9):2475\u201387.","journal-title":"Eur J Immunol"},{"issue":"8","key":"525_CR12","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/sj.onc.1206184","volume":"22","author":"S Majumdar","year":"2003","unstructured":"Majumdar S, Aggarwal BB. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene. 2003;22(8):1206\u201318.","journal-title":"Oncogene"},{"issue":"2","key":"525_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cbpc.2003.11.010","volume":"137","author":"S Iwaki-Egawa","year":"2004","unstructured":"Iwaki-Egawa S, Namiki C, Watanabe Y. Adenosine deaminase 2 from chicken liver: purification, characterization, and N-terminal amino acid sequence. Comp Biochem Physiol B Biochem Mol Biol. 2004;137(2):247\u201354.","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"3","key":"525_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1515\/BC.2006.042","volume":"387","author":"S Iwaki-Egawa","year":"2006","unstructured":"Iwaki-Egawa S, Yamamoto T, Watanabe Y. Human plasma adenosine deaminase 2 is secreted by activated monocytes. Biol Chem. 2006;387(3):319\u201321.","journal-title":"Biol Chem"},{"issue":"16","key":"525_CR15","doi-asserted-by":"publisher","first-page":"12367","DOI":"10.1074\/jbc.M109.083527","volume":"285","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Yu X, Spillmann D, Lauvau G, Zavialov AV. Structural basis for the growth factor activity of human adenosine deaminase ADA2. J Biol Chem. 2010;285(16):12367\u201377.","journal-title":"J Biol Chem"},{"issue":"9","key":"525_CR16","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1084\/jem.192.9.1223","volume":"192","author":"E Richard","year":"2000","unstructured":"Richard E, Arredondo-Vega FX, Santisteban I, Kelly SJ, Patel DD, Hershfield MS. The binding site of human adenosine deaminase for CD26\/dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency. J Exp Med. 2000;192(9):1223\u201336.","journal-title":"J Exp Med"},{"issue":"4","key":"525_CR17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4049\/jimmunol.156.4.1349","volume":"156","author":"RP Dong","year":"1996","unstructured":"Dong RP, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF, et al. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol. 1996;156(4):1349\u201355.","journal-title":"J Immunol"},{"issue":"23","key":"525_CR18","doi-asserted-by":"publisher","first-page":"13770","DOI":"10.1074\/jbc.271.23.13770","volume":"271","author":"K Homma","year":"1996","unstructured":"Homma K, Matsushita T, Natori S. Purification, characterization, and cDNA cloning of a novel growth factor from the conditioned medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina (flesh fly). J Biol Chem. 1996;271(23):13770\u20135.","journal-title":"J Biol Chem"},{"issue":"47","key":"525_CR19","doi-asserted-by":"publisher","first-page":"43761","DOI":"10.1074\/jbc.M105088200","volume":"276","author":"KJ Homma","year":"2001","unstructured":"Homma KJ, Tanaka Y, Matsushita T, Yokoyama K, Matsui H, Natori S. Adenosine deaminase activity of insect-derived growth factor is essential for its growth factor activity. J Biol Chem. 2001;276(47):43761\u20136.","journal-title":"J Biol Chem"},{"issue":"7","key":"525_CR20","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1073\/pnas.062059699","volume":"99","author":"M Zurovec","year":"2002","unstructured":"Zurovec M, Dolezal T, Gazi M, Pavlova E, Bryant PJ. Adenosine deaminase-related growth factors stimulate cell proliferation in Drosophila by depleting extracellular adenosine. Proc Natl Acad Sci U S A. 2002;99(7):4403\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"525_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ibmb.2004.12.009","volume":"35","author":"E Dolezelova","year":"2005","unstructured":"Dolezelova E, Zurovec M, Dolezal T, Simek P, Bryant PJ. The emerging role of adenosine deaminases in insects. Insect Biochem Mol Biol. 2005;35(5):381\u20139.","journal-title":"Insect Biochem Mol Biol"},{"issue":"7","key":"525_CR22","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1371\/journal.pbio.0030201","volume":"3","author":"T Dolezal","year":"2005","unstructured":"Dolezal T, Dolezelova E, Zurovec M, Bryant PJ. A role for adenosine deaminase in Drosophila larval development. PLoS Biol. 2005;3(7):e201.","journal-title":"PLoS Biol"},{"issue":"3","key":"525_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1006\/geno.1999.6099","volume":"64","author":"MA Riazi","year":"2000","unstructured":"Riazi MA, Brinkman-Mills P, Nguyen T, Pan H, Phan S, Ying F, et al. The human homolog of insect-derived growth factor, CECR1, is a candidate gene for features of cat eye syndrome. Genomics. 2000;64(3):277\u201385.","journal-title":"Genomics"},{"issue":"4","key":"525_CR24","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1074\/jbc.M709279200","volume":"283","author":"R Iijima","year":"2008","unstructured":"Iijima R, Kunieda T, Yamaguchi S, Kamigaki H, Fujii-Taira I, Sekimizu K, et al. The extracellular adenosine deaminase growth factor, ADGF\/CECR1, plays a role in Xenopus embryogenesis via the adenosine\/P1 receptor. J Biol Chem. 2008;283(4):2255\u201364.","journal-title":"J Biol Chem"},{"issue":"3","key":"525_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11248-005-1174-2","volume":"14","author":"AM Riazi","year":"2005","unstructured":"Riazi AM, Van Arsdell G, Buchwald M. Transgenic expression of CECR1 adenosine deaminase in mice results in abnormal development of heart and kidney. Transgenic Res. 2005;14(3):333\u20136.","journal-title":"Transgenic Res"},{"issue":"5","key":"525_CR26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/CDLI.2.5.626-630.1995","volume":"2","author":"I Tsuboi","year":"1995","unstructured":"Tsuboi I, Sagawa K, Shichijo S, Yokoyama MM, Ou DW, Wiederhold MD. Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections. Clin Diagn Lab Immunol. 1995;2(5):626\u201330.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"525_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4046\/trd.2017.80.1.77","volume":"80","author":"MJ Bae","year":"2017","unstructured":"Bae MJ, Ryu S, Kim HJ, Cha SI, Kim CH, Lee J. Mycobacterium tuberculosis ESAT6 and CPF10 induce adenosine deaminase 2 mRNA expression in monocyte-derived macrophages. Tuberc Respir Dis (Seoul). 2017;80(1):77\u201382.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"2","key":"525_CR28","first-page":"178","volume":"4","author":"JG Niedzwicki","year":"1991","unstructured":"Niedzwicki JG, Kouttab NM, Mayer KH, Carpenter CC, Parks RE Jr, Abushanab E, et al. Plasma adenosine deaminase2: a marker for human immunodeficiency virus infection. J Acquir Immune Defic Syndr. 1991;4(2):178\u201382.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"525_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1183\/09031936.96.09040747","volume":"9","author":"L Valdes","year":"1996","unstructured":"Valdes L, San Jose E, Alvarez D, Valle JM. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J. 1996;9(4):747\u201351.","journal-title":"Eur Respir J"},{"key":"525_CR30","doi-asserted-by":"crossref","unstructured":"Valadbeigi S, Ebrahimi-Rad M, Khatami S, Akhbari H, Saghiri R. Adenosine deaminase activity and HLA-DRB as diagnostic markers for rheumatoid arthritis. Curr Rheumatol Rev 2018.","DOI":"10.2174\/1573397114666180406101239"},{"issue":"1","key":"525_CR31","first-page":"87","volume":"21","author":"RA Sari","year":"2003","unstructured":"Sari RA, Taysi S, Yilmaz O, Bakan N. Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol. 2003;21(1):87\u201390.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"525_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00004836-200003000-00011","volume":"30","author":"E Fernandez","year":"2000","unstructured":"Fernandez E, Rodrigo L, Riestra S, Carcia S, Gutierrez F, Ocio G. Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J Clin Gastroenterol. 2000;30(2):181\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"525_CR33","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jaci.2012.08.054","volume":"131","author":"G Marca la","year":"2013","unstructured":"la Marca G, Canessa C, Giocaliere E, Romano F, Duse M, Malvagia S, et al. Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency. J Allergy Clin Immunol. 2013;131(6):1604\u201310.","journal-title":"J Allergy Clin Immunol"},{"issue":"27","key":"525_CR34","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.1073\/pnas.0501050102","volume":"102","author":"R Pacheco","year":"2005","unstructured":"Pacheco R, Martinez-Navio JM, Lejeune M, Climent N, Oliva H, Gatell JM, et al. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci U S A. 2005;102(27):9583\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"525_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1615\/CritRevImmunol.v27.i6.10","volume":"27","author":"R Franco","year":"2007","unstructured":"Franco R, Pacheco R, Gatell JM, Gallart T, Lluis C. Enzymatic and extraenzymatic role of adenosine deaminase 1 in T-cell-dendritic cell contacts and in alterations of the immune function. Crit Rev Immunol. 2007;27(6):495\u2013509.","journal-title":"Crit Rev Immunol"},{"issue":"3","key":"525_CR36","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","volume":"74","author":"Y Kaljas","year":"2017","unstructured":"Kaljas Y, Liu C, Skaldin M, Wu C, Zhou Q, Lu Y, et al. Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cell Mol Life Sci. 2017;74(3):555\u201370.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"525_CR37","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jaci.2015.07.053","volume":"137","author":"F Fellmann","year":"2016","unstructured":"Fellmann F, Angelini F, Wassenberg J, Perreau M, Arenas Ramirez N, Simon G, et al. IL-17 receptor a and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation. J Allergy Clin Immunol. 2016;137(4):1189\u201396.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"525_CR38","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","volume":"55","author":"JM Montfrans Van","year":"2016","unstructured":"Van Montfrans JM, Hartman EA, Braun KP, Hennekam EA, Hak EA, Nederkoorn PJ, et al. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatology (Oxford). 2016;55(5):902\u201310.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"525_CR39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc1405506","volume":"371","author":"J Bras","year":"2014","unstructured":"Bras J, Guerreiro R, Santo GC. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):478\u201380.","journal-title":"N Engl J Med"},{"issue":"5","key":"525_CR40","first-page":"480","volume":"371","author":"L Eyck Van","year":"2014","unstructured":"Van Eyck L, Liston A, Wouters C. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):480.","journal-title":"N Engl J Med"},{"key":"525_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1546-0096-12-44","volume":"12","author":"A Belot","year":"2014","unstructured":"Belot A, Wassmer E, Twilt M, Lega JC, Zeef LA, Oojageer A, et al. Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J. 2014;12:44.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"20","key":"525_CR42","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1212\/WNL.0000000000001581","volume":"84","author":"WF Westendorp","year":"2015","unstructured":"Westendorp WF, Nederkoorn PJ, Aksentijevich I, Hak AE, Lichtenbelt KD, Braun KP. Unexplained early-onset lacunar stroke and inflammatory skin lesions: consider ADA2 deficiency. Neurology. 2015;84(20):2092\u20133.","journal-title":"Neurology"},{"issue":"11","key":"525_CR43","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1001\/jamadermatol.2015.1635","volume":"151","author":"TM Gonzalez Santiago","year":"2015","unstructured":"Gonzalez Santiago TM, Zavialov A, Saarela J, Seppanen M, Reed AM, Abraham RS, et al. Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa. JAMA Dermatol. 2015;151(11):1230\u20134.","journal-title":"JAMA Dermatol"},{"issue":"8","key":"525_CR44","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3899\/jrheum.150024","volume":"42","author":"ED Batu","year":"2015","unstructured":"Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M, et al. A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations. J Rheumatol. 2015;42(8):1532\u20134.","journal-title":"J Rheumatol"},{"issue":"8","key":"525_CR45","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.40147","volume":"69","author":"J Schepp","year":"2017","unstructured":"Schepp J, Proietti M, Frede N, Buchta M, Hubscher K, Rojas Restrepo J, et al. Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheumatol. 2017;69(8):1689\u2013700.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"525_CR46","doi-asserted-by":"publisher","first-page":"e000236","DOI":"10.1136\/rmdopen-2015-000236","volume":"2","author":"F Uettwiller","year":"2016","unstructured":"Uettwiller F, Sarrabay G, Rodero MP, Rice GI, Lagrue E, Marot Y, et al. ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters. RMD Open. 2016;2(1):e000236.","journal-title":"RMD Open"},{"key":"525_CR47","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","volume":"177","author":"T Ben-Ami","year":"2016","unstructured":"Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, et al. Extending the clinical phenotype of adenosine deaminase 2 deficiency. J Pediatr. 2016;177:316\u201320.","journal-title":"J Pediatr"},{"issue":"4","key":"525_CR48","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s00415-016-8070-y","volume":"263","author":"O Poswar Fde","year":"2016","unstructured":"Poswar Fde O, da Fonseca RM, de Albuquerque LC, Zhou Q, Jardim LB, Monte TL, et al. Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis. J Neurol. 2016;263(4):818\u201320.","journal-title":"J Neurol"},{"issue":"9","key":"525_CR49","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","volume":"68","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, et al. Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheumatol. 2016;68(9):2314\u201322.","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"525_CR50","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","volume":"76","author":"R Caorsi","year":"2017","unstructured":"Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis. 2017;76(10):1648\u201356.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"525_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12969-017-0193-x","volume":"15","author":"A Skrabl-Baumgartner","year":"2017","unstructured":"Skrabl-Baumgartner A, Plecko B, Schmidt WM, Konig N, Hershfield M, Gruber-Sedlmayr U, et al. Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation. Pediatr Rheumatol Online J. 2017;15(1):67.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"525_CR52","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/03009742.2017.1324912","volume":"47","author":"H Nihira","year":"2018","unstructured":"Nihira H, Nakagawa K, Izawa K, Kawai T, Yasumi T, Nishikomori R, et al. Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type 2 deficiency. Scand J Rheumatol. 2018;47(2):170\u20132.","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"525_CR53","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/rheumatology\/kew050","volume":"55","author":"N Keer","year":"2016","unstructured":"Keer N, Hershfield M, Caskey T, Unizony S. Novel compound heterozygous variants in CECR1 gene associated with childhood onset polyarteritis nodosa and deficiency of ADA2. Rheumatology (Oxford). 2016;55(6):1145\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"525_CR54","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1097\/MPH.0000000000000805","volume":"39","author":"H Hashem","year":"2017","unstructured":"Hashem H, Egler R, Dalal J. Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2. J Pediatr Hematol Oncol. 2017;39(5):e293\u2013e6.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"24","key":"525_CR55","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","volume":"130","author":"H Hashem","year":"2017","unstructured":"Hashem H, Kumar AR, Muller I, Babor F, Bredius R, Dalal J, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017;130(24):2682\u20138.","journal-title":"Blood"},{"key":"525_CR56","doi-asserted-by":"publisher","unstructured":"Alsultan A, Basher E, Alqanatish J, Mohammed R, Alfadhel M. Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis. Pediatr Blood Cancer 2018;65(4). https:\/\/doi.org\/10.1002\/pbc.26912 .","DOI":"10.1002\/pbc.26912"},{"key":"525_CR57","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","volume":"141","author":"L Trotta","year":"2018","unstructured":"Trotta L, Martelius T, Siitonen T, Hautala T, Hamalainen S, Juntti H, et al. ADA2 deficiency: clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol. 2018;141:1534\u20131537.e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"525_CR58","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10875-018-0480-4","volume":"38","author":"TF Michniacki","year":"2018","unstructured":"Michniacki TF, Hannibal M, Ross CW, Frame DG, DuVall AS, Khoriaty R, et al. Hematologic manifestations of deficiency of adenosine deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in DADA2-associated bone marrow failure. J Clin Immunol. 2018;38(2):166\u201373.","journal-title":"J Clin Immunol"},{"key":"525_CR59","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10875-018-0487-x","volume":"38","author":"FE Cipe","year":"2018","unstructured":"Cipe FE, Aydogmus C, Serwas NK, Keskindemirci G, Boztug K. Novel mutation in CECR1 leads to deficiency of ADA2 with associated neutropenia. J Clin Immunol. 2018;38:273\u20137.","journal-title":"J Clin Immunol"},{"key":"525_CR60","doi-asserted-by":"publisher","unstructured":"Rama M, Duflos C, Melki I, Bessis D, Bonhomme A, Martin H, Doummar D, Valence S, Rodriguez D, Carme E, Genevieve D, Heimdal K, Insalaco A, Franck N, Queyrel-Moranne V, Tieulie N, London J, Uettwiller F, Georgin-Lavialle S, Belot A, Kon\u00e9-Paut I, Hentgen V, Boursier G, Touitou I, Sarrabay G A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Eur J Hum Genet 2018. https:\/\/doi.org\/10.1038\/s41431-018-0130-6 .","DOI":"10.1038\/s41431-018-0130-6"},{"issue":"4","key":"525_CR61","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jaci.2016.08.003","volume":"138","author":"I Meyts","year":"2016","unstructured":"Meyts I, Bosch B, Bolze A, Boisson B, Itan Y, Belkadi A, et al. Exome and genome sequencing for inborn errors of immunity. J Allergy Clin Immunol. 2016;138(4):957\u201369.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"525_CR62","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","volume":"50","author":"R Malik","year":"2018","unstructured":"Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524\u201337.","journal-title":"Nat Genet"},{"issue":"9","key":"525_CR63","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1161\/STROKEAHA.115.009485","volume":"46","author":"M Traylor","year":"2015","unstructured":"Traylor M, Bevan S, Baron JC, Hassan A, Lewis CM, Markus HS. Genetic architecture of lacunar stroke. Stroke. 2015;46(9):2407\u201312.","journal-title":"Stroke"},{"issue":"38","key":"525_CR64","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1038\/onc.2017.145","volume":"36","author":"C Zhu","year":"2017","unstructured":"Zhu C, Chrifi I, Mustafa D, van der Weiden M, Leenen PJM, Duncker DJ, et al. CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma. Oncogene. 2017;36(38):5356\u201368.","journal-title":"Oncogene"},{"issue":"3","key":"525_CR65","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10875-016-0245-x","volume":"36","author":"J Schepp","year":"2016","unstructured":"Schepp J, Bulashevska A, Mannhardt-Laakmann W, Cao H, Yang F, Seidl M, et al. Deficiency of adenosine deaminase 2 causes antibody deficiency. J Clin Immunol. 2016;36(3):179\u201386.","journal-title":"J Clin Immunol"},{"issue":"2","key":"525_CR66","first-page":"111","volume":"48","author":"M Elbracht","year":"2017","unstructured":"Elbracht M, Mull M, Wagner N, Kuhl C, Abicht A, Kurth I, et al. Stroke as initial manifestation of adenosine deaminase 2 deficiency. Neuropediatrics. 2017;48(2):111\u20134.","journal-title":"Neuropediatrics"},{"issue":"1","key":"525_CR67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00296-017-3740-3","volume":"38","author":"S Sahin","year":"2018","unstructured":"Sahin S, Adrovic A, Barut K, Ugurlu S, Turanli ET, Ozdogan H, et al. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency. Rheumatol Int. 2018;38(1):129\u201336.","journal-title":"Rheumatol Int"},{"key":"525_CR68","unstructured":"Lamprecht P, Humrich JY, Diebold I, Riemekasten G. Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation. Clin Exp Rheumatol 2018;36:S111(2):177."},{"key":"525_CR69","doi-asserted-by":"publisher","unstructured":"Sundin M, Marits P, Nierkens S, Kolios AGA, Nilsson J. \u201cImmune\u201d thrombocytopenia as key feature of a novel ADA2 deficiency variant: implication on differential diagnostics of ITP in children. J Pediatr Hematol Oncol 2018. https:\/\/doi.org\/10.1097\/MPH.0000000000001132 .","DOI":"10.1097\/MPH.0000000000001132"},{"issue":"2","key":"525_CR70","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaci.2016.03.016","volume":"138","author":"AP Hsu","year":"2016","unstructured":"Hsu AP, West RR, Calvo KR, Cuellar-Rodriguez J, Parta M, Kelly SJ, et al. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: successful hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2016;138(2):628\u2013630.e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"525_CR71","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc1405506","volume":"371","author":"J Montfrans van","year":"2014","unstructured":"van Montfrans J, Zavialov A, Zhou Q. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):478.","journal-title":"N Engl J Med"},{"issue":"1","key":"525_CR72","doi-asserted-by":"publisher","first-page":"O40","DOI":"10.1186\/1546-0096-13-S1-O40","volume":"13","author":"ASD Ombrello","year":"2015","unstructured":"Ombrello ASD, Hoffmann P, Jones A, Barham B, Barron K, Flegel W, et al. The deficiency of adenosine deaminase type 2-results of therapeutic intervention. Pediatr Rheumatol. 2015;13(1):O40.","journal-title":"Pediatr Rheumatol"},{"issue":"8","key":"525_CR73","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-017-0449-8","volume":"37","author":"G Bucciol","year":"2017","unstructured":"Bucciol G, Delafontaine S, Segers H, Bossuyt X, Hershfield MS, Moens L, et al. Hematopoietic stem cell transplantation in ADA2 deficiency: early restoration of ADA2 enzyme activity and disease relapse upon drop of donor chimerism. J Clin Immunol. 2017;37(8):746\u201350.","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-018-0525-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0525-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0525-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T06:50:36Z","timestamp":1693723836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-018-0525-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1007\/s10875-018-0525-8","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,27]]},"assertion":[{"value":"1 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}